ArticleFrontiers in genetics2024

Comprehensive pan-cancer analysis and experiments revealed R3HDM1 as a novel predictive biomarker for prognosis and immune therapy response.

Jiawei Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.